Streamlining the Antibody Discovery Workflow at ModiQuest Research

With breakthroughs in molecular engineering and antibody humanization, monoclonal antibodies (mAbs) are one of the fastest growing classes of biopharmaceuticals for most clinical indications. The Intellicyt platform provides an integrated solution that rapidly produces actionable results driving antibody discovery and development forward. The Intellicyt^® iQue Screener platform combines high throughput sampling, flow cytometry detection, and onboard analysis with plate level analytics that deliver rich content with sampling times of less than 20 minutes for a 384 well plate. Eliminating the dead volumes of traditional flow cytometry, assay volumes can be reduced to microliters saving precious cells and reagent costs. Data acquisition, analysis, and visualization happen on the fly for each plate using user-defined templates, dramatically reducing the time and effort to generate useful results.